Hikma has nearly 5,000 employees in the MENA. They have local manufacturing facilities in seven markets and sales and marketing teams detailing doctors and pharmacists across 17 markets.

Hikma Pharmaceuticals has a comprehensive CNS portfolio for the management and treatment of Neurological Diseases (such as Epilepsy, Migraine and Alzheimer’s disease), among them is Fycompa.

For more details kindly visit: http://www.hikma.com